How 'sham' brain surgery could be killing off valuable therapies for Parkinson's disease.
This is a preview of subscription content, log in via an institution to check access.
References
Stover, N. P. & Watts, R. L. Neurotherapeutics 5, 252-259 (2008).
Gross, R. E. et al. Lancet Neurol. 10, 509-519 (2011).
Madrazo, I. et al. N. Engl. J. Med. 316, 831-834 (1987).
Marks, W. J. et al. Lancet Neurol. 9, 1164-1172 (2010).
Freed, C. R. et al. N. Engl. J. Med. 344, 710-719 (2001).
Olanow, C. W. et al. Ann. Neurol. 54, 403-414 (2003).
Marks, W. J. et al. Lancet Neurol. 7, 400-408 (2008).
Gill, S. S. et al. Nature Med. 9, 589-595 (2003).
Lang, A. E. et al. Ann. Neurol. 59, 459-466 (2006).
Kim, S. Y. H. et al. Arch. Neurol. 62, 1357-1360 (2005).
de la Fuente-Fernández, R. et al. Science 293, 1164-1166 (2001).
McRae, C. et al. Arch. Gen. Psychiatry 61, 412-420 (2004).
Politis, M. et al. Sci. Transl. Med. 2, 38ra46 (2010).
Kaplitt, M. G. et al. Lancet 369, 2097-2105 (2007).
LeWitt, P. A. et al. Lancet Neurol. 10, 309-319 (2011).
Additional information
Alla Katsnelson is a freelance science writer in New York City.
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Katsnelson, A. Experimental therapies for Parkinson's disease: Why fake it?. Nature 476, 142–144 (2011). https://doi.org/10.1038/476142a
Published:
Issue Date:
DOI: https://doi.org/10.1038/476142a
- Springer Nature Limited
This article is cited by
-
Differentiation of adult human retinal pigment epithelial cells into dopaminergic-like cells in vitro and in the recipient monkey brain
Molecular Medicine (2019)
-
Differential behavioral outcomes following neonatal versus fetal human retinal pigment epithelial cell striatal implants in parkinsonian rats
Journal of Neural Transmission (2017)